Q2 Outliers: 16 Stocks Beating Earnings Estimates
Although technology and AI have remained central to the growth narrative in the second-quarter earnings season, the latest data shows that this season is not just a tech earnings story.
Aveanna Healthcare Holdings Inc. (AVAH)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Nut Tree Capital Jared Nussbaum | 12,922,649 | $110,747,102 | 26.43% | |
| 2. | Ophir Asset Management Steven Ng And Andrew Mitchell | 5,100,000 | $43,707,000 | 3.59% | |
| 3. | Braidwell LP Alex Karnal | 3,065,106 | $26,267,958 | +40% | 0.97% |
| 4. | Citadel Investment Group Ken Griffin | 2,285,756 | $19,588,929 | +726% | 0% |
| 5. | Point72 Asset Management Steve Cohen | 1,803,451 | $15,455,575 | +1692% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.23 | 200 | $246.00 | 236,617 | 2023-06-06 | Filing | |
| $1.18 | 3,200 | $3,776.00 | 236,417 | 2023-06-01 | Filing | |
| $1.15 | 11,850 | $13,615.65 | 233,217 | 2023-05-31 | Filing | |
| $1.14 | 1,758 | $2,007.64 | 221,367 | 2023-05-30 | Filing | |
| $2.01 | 10,000 | $20,140.00 | 288,240 | 2022-08-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.01 | 55,121 | $441,519.21 | 190,130 | 2026-06-30 | Filing | |
| $8.01 | 525,844 | $4,212,010.44 | 1,813,795 | 2026-06-30 | Filing | |
| $8.01 | 2,419,035 | $19,376,470.35 | 10,112,123 | 2026-06-30 | Filing | |
| $8.01 | 55,121 | $441,519.21 | 190,130 | 2026-06-30 | Filing | |
| $8.01 | 525,844 | $4,212,010.44 | 1,813,795 | 2026-06-30 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 81,600,880 | $699,319,542 | 14.52% | |
| 2. | 27,061,967 | $231,921,057 | 100% | |
| 3. | 7,410,053 | $63,504,156 | 0% | |
| 4. | 3,673,218 | $31,479,478 | 0% | |
| 5. | 2,870,979 | $24,924,466 | 0.02% |
News See All
10 Best Future Stocks to Buy Under $10
On July 8, Tim Urbanowicz, Innovator's Head of Research, joined 'Power Lunch' to discuss the state of small-cap stocks and his outlook for the remainder of the year.
10 Best Cheap Stocks Under $10 to Buy in June
On May 27, Kathleen Entwistle, Morgan Stanley Private Wealth Management Managing Director & Private Wealth Advisor, joined 'Fast Money' on CNBC to talk about buying opportunities in the current market...
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Q1 2026 Earnings Call Transcript
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Q1 2026 Earnings Call Transcript May 14, 2026Aveanna Healthcare Holdings Inc. beats earnings expectations.
Truist Cuts PT on Aveanna Healthcare Holdings Inc. (AVAH) to $8 From $9
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) is one of the most oversold healthcare stocks to invest in. Truist cut the price target on Aveanna Healthcare Holdings Inc.
8 Most Oversold Healthcare Stocks to Invest In
Calling it a textbook classic move, he stated that we had a geopolitical shock and markets sold off hard before snapping right back up, making it the classic V shape.
Barclays Adjusts Aveanna Healthcare Holdings Inc. (AVAH) Outlook After Q4 Results, Keeps Overweight Rating
TheFly reported on March 25 that Barclays announced a reduction in AVAH price target to $9.50 from $11 while retaining an Overweight rating.
10 Best Cheap Stocks Under $10 to Buy in April
As U.S. economic growth slows, Bank of America strategists have highlighted growing stagflation risks and warned that the markets are becoming more susceptible.
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Q4 2025 Earnings Call Transcript
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Q4 2025 Earnings Call Transcript March 19, 2026Aveanna Healthcare Holdings Inc. beats earnings expectations.
10 Hottest Small Cap Stocks to Buy Now
On November 12, Scott Chronert, Citi's U.S. equity strategist, appeared on a CNBC Television interview to discuss his bullish case for small- and mid-cap stocks.
Hedge Fund Resource Center